Cargando…
Preclinical Evaluation of a Novel (18)F-Labeled dTCO-Amide Derivative for Bioorthogonal Pretargeted Positron Emission Tomography Imaging
[Image: see text] Pretargeted positron emission tomography (PET) imaging based on the bioorthogonal inverse-electron-demand Diels–Alder reaction between tetrazines (Tz) and trans-cyclooctenes (TCO) has emerged as a promising tool for solid tumor imaging, allowing the use of short-lived radionuclides...
Autores principales: | Ruivo, Eduardo, Elvas, Filipe, Adhikari, Karuna, Vangestel, Christel, Van Haesendonck, Glenn, Lemière, Filip, Staelens, Steven, Stroobants, Sigrid, Van der Veken, Pieter, wyffels, Leonie, Augustyns, Koen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066555/ https://www.ncbi.nlm.nih.gov/pubmed/32175492 http://dx.doi.org/10.1021/acsomega.9b03584 |
Ejemplares similares
-
Characterization
of Structurally Diverse (18)F-Labeled d-TCO
Derivatives as a PET Probe for Bioorthogonal
Pretargeted Imaging
por: Adhikari, Karuna, et al.
Publicado: (2023) -
Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis
por: Elvas, Filipe, et al.
Publicado: (2015) -
Pretargeted Imaging and Radioimmunotherapy of Cancer Using Antibodies and Bioorthogonal Chemistry
por: van de Watering, Floor C. J., et al.
Publicado: (2014) -
How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research
por: De Bruycker, Sven, et al.
Publicado: (2018) -
Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update
por: Dewulf, Jonatan, et al.
Publicado: (2020)